Efficacy of influenza vaccine in adults. Systematic review

Yasmin González

SAP Multidisciplinary Open, 2023

Abstract: This study addresses the challenges and advances in the vaccination of older adults in a context of global population aging, evaluating its effectiveness in the prevention of serious infectious diseases. Immunosenescence and comorbidities in this population may affect the response to vaccines, decreasing their efficacy. Through a systematic review, we analyzed recent studies evaluating various vaccine formulations and strategies such as high doses, natural adjuvants (e.g., probiotics and nondigestible polysaccharides), and vaccine coadministration to optimize immunogenicity in the elderly. The results show that high-dose quadrivalent vaccines (QIV-HD) and formulations with natural adjuvants improve immune response and reduce hospitalizations compared to standard doses. Coadministration of vaccines, such as influenza and COVID-19, is a safe practice that does not compromise the efficacy of each vaccine and facilitates vaccination in this high-risk population. The findings support the use of tailored vaccination strategies and underscore the need for additional studies to establish evidence-based recommendations for immunization in older adults.

Date: 2023
References: Add references at CitEc
Citations:

Downloads: (external link)
https://southam.pub/journals/files/mo/mo202334en.pdf (application/pdf)
https://southam.pub/journals/files/mo/mo202334es.pdf (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:cwf:moarti:mo202334

DOI: 10.62486/mo202334

Access Statistics for this article

More articles in SAP Multidisciplinary Open from South American Publishing
Bibliographic data for series maintained by South American Publishing Journals Manager ().